S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Pardes Biosciences (PRDS) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
yahoo.com logoPardes Hanna, Israel - Weather Forecasts | Maps | News - Yahoo Weather
yahoo.com - October 31 at 1:12 PM
finance.yahoo.com logoPardes Biosciences Announces Closing of Tender Offer
finance.yahoo.com - August 31 at 9:39 AM
marketbeat.com logo
marketbeat.com - August 31 at 6:01 AM
finance.yahoo.com logoMediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences
finance.yahoo.com - August 28 at 1:21 PM
finance.yahoo.com logoMediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares
finance.yahoo.com - August 17 at 6:38 PM
msn.com logoPardes Biosciences (PRDS) Price Target Decreased by 28.57% to 1.28
msn.com - August 3 at 9:10 PM
marketwatch.com logoPardes Biosciences Shares Rise 15% After Buyout Offer From MediPacific
marketwatch.com - July 19 at 4:18 PM
markets.businessinsider.com logoSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Pardes Bioscience, Inc. (PRDS)
markets.businessinsider.com - July 19 at 4:18 PM
msn.com logoJMP Securities Downgrades Pardes Biosciences (PRDS)
msn.com - July 18 at 5:51 PM
benzinga.com logoPRDS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Pardes Biosciences, Inc. Is Fair to Shareholders
benzinga.com - July 17 at 3:27 PM
msn.com logoPardes Biosciences stock rallies on buyout offer from MediPacific
msn.com - July 17 at 10:26 AM
benzinga.com logoWhy Pardes Biosciences Shares Are Rising Monday
benzinga.com - July 17 at 10:26 AM
markets.businessinsider.com logoPardes Biosciences To Be Acquired By MediPacific; Pardes Up In Pre-market
markets.businessinsider.com - July 17 at 10:26 AM
finance.yahoo.com logoPardes Biosciences Enters into Agreement to be Acquired by MediPacific, Inc. for between $2.02 and $2.19 in Cash per Share Plus Contingent Value Rights
finance.yahoo.com - July 17 at 10:26 AM
marketbeat.com logo
marketbeat.com - July 17 at 6:56 AM
finance.yahoo.com logoAll You Need to Know About Pardes Biosciences, Inc. (PRDS) Rating Upgrade to Buy
finance.yahoo.com - June 5 at 5:45 PM
seekingalpha.com logoPardes Biosciences Seeking Strategic Alternatives
seekingalpha.com - May 17 at 11:43 PM
markets.businessinsider.com logoPardes Biosciences (PRDS) Receives a Hold from SVB Securities
markets.businessinsider.com - May 9 at 7:23 AM
barrons.com logoPardes Biosciences Inc.
barrons.com - May 6 at 11:25 PM
finanznachrichten.de logoPardes Biosciences, Inc: Pardes Biosciences Reports First Quarter 2023 Financial Results
finanznachrichten.de - May 6 at 8:24 AM
msn.com logoRecap: Pardes Biosciences Q1 Earnings
msn.com - May 5 at 8:30 PM
finance.yahoo.com logoPardes Biosciences Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 5 at 8:30 PM
benzinga.com logoAnalyst Rating: Will Pardes Biosciences Inc (PRDS) Stock Do Better Than the Market?
benzinga.com - April 12 at 6:58 PM
seekingalpha.com logoPardes Biosciences cut at Jefferies on COVID drug failure
seekingalpha.com - April 7 at 12:22 AM
msn.com logoSVB Leerink Downgrades FS Development Corp II (PRDS)
msn.com - April 4 at 10:58 PM
markets.businessinsider.com logoSVB Securities downgrades Pardes Biosciences (PRDS) to a Hold
markets.businessinsider.com - April 4 at 7:37 AM
msn.com logoPardes slumps ~10% after COVID drug trial failure prompts strategic review
msn.com - April 3 at 4:26 PM
msn.com logoPardes Biosciences Looks For Alternatives After Failed COVID-19 Study
msn.com - April 3 at 4:26 PM
finance.yahoo.com logoWill Pardes Biosciences (NASDAQ:PRDS) Spend Its Cash Wisely?
finance.yahoo.com - April 3 at 9:42 AM
reuters.com logoPardes Biosciences to suspend COVID-19 drug development after mid-stage trial fails
reuters.com - April 3 at 9:42 AM
finance.yahoo.com logoPardes Biosciences Announces Top-line Results from Phase 2 Trial Evaluating Pomotrelvir for the Treatment of COVID-19
finance.yahoo.com - April 3 at 9:42 AM
marketbeat.com logo
marketbeat.com - April 3 at 7:57 AM
markets.businessinsider.com logoSVB Securities Reaffirms Their Buy Rating on Pardes Biosciences (PRDS)
markets.businessinsider.com - March 20 at 10:22 AM
benzinga.com logoPardes Biosciences Stock (NASDAQ:PRDS), Guidance and Forecast
benzinga.com - March 16 at 4:53 AM
finance.yahoo.com logoPardes Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
finance.yahoo.com - March 14 at 4:18 PM
finance.yahoo.com logoPardes Biosciences to Present at SVB Securities Global Biopharma Conference
finance.yahoo.com - February 1 at 10:42 AM
prnewswire.com logoRM LAW Announces Investigation of Pardes Biosciences, Inc.
prnewswire.com - January 30 at 7:16 PM
marketbeat.com logoIeq Capital LLC Invests $105,000 in Pardes Biosciences, Inc. (NASDAQ:PRDS)
marketbeat.com - January 30 at 5:35 AM
marketbeat.com logoPardes Biosciences, Inc. to Post FY2026 Earnings of $4.35 Per Share, SVB Leerink Forecasts (NASDAQ:PRDS)
marketbeat.com - January 30 at 2:55 AM
marketbeat.com logoPardes Biosciences (NASDAQ:PRDS) PT Lowered to $9.00
marketbeat.com - January 27 at 8:30 AM
seekingalpha.com logoPRDS Pardes Biosciences, Inc.
seekingalpha.com - January 25 at 1:41 PM
benzinga.com logo(SPAC) Special Purpose Acquisition Investigation: KIND, OPFI, OTMO, PRDS, Contact Shareholder Rights Law Firm Johnson Fistel
benzinga.com - January 14 at 10:22 PM
finance.yahoo.com logoPardes Biosciences, Inc. (NASDAQ:PRDS) Is Expected To Breakeven In The Near Future
finance.yahoo.com - November 13 at 6:59 PM
apnews.com logoPardes Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
apnews.com - November 8 at 12:02 PM
finance.yahoo.com logoPardes Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - November 8 at 12:02 PM
finance.yahoo.com logoPardes Biosciences to Present at Jefferies London Healthcare Conference
finance.yahoo.com - November 1 at 2:24 PM
finance.yahoo.com logoHere's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation
finance.yahoo.com - September 28 at 5:11 PM
finance.yahoo.com logoPardes Biosciences Appoints Laurie Smaldone Alsup, M.D. and John C. Pottage, Jr., M.D. to Board of Directors
finance.yahoo.com - September 14 at 12:50 PM
finance.yahoo.com logoPardes Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 12 at 10:43 AM
finance.yahoo.com logoPardes Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 12 at 10:43 AM
Get Pardes Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRDS and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

PRDS Media Mentions By Week

PRDS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRDS
News Sentiment

0.00

0.50

Average
Medical
News Sentiment

PRDS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRDS Articles
This Week

0

0

PRDS Articles
Average Week

Get Pardes Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRDS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PRDS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners